Phenotyping of circulating CD8 + T cell subsets in human cutaneous leishmaniasis

Microbes and Infection

Volumn 14, Issue 9, 2012, Pages 702-711

  Khamesipour, Ali ^a   Nateghi Rostami, Mahmoud ^b   Tasbihi, Minoo ^a   Miramin Mohammadi, Akram ^a   Shahrestani, Tahereh ^c   Sarrafnejad, Abdolfattah ^c   Sohrabi, Yahya ^d   Eskandari, Seyed Ebrahim ^a   Keshavarz Valian, Hossein ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

CD8 + t cells; Cutaneous leishmaniasis; IFN ; Memory t cells

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD45RA ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; LYMPHOCYTE SURFACE MARKER;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

ADULT; ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; RECEPTORS, CCR7; T-LYMPHOCYTE SUBSETS;

EID: 84863097031     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.02.006     Document Type: Article

References (50)

1. WHO Working to Overcome the Global Impact of Neglected Diseases: First WHO Report on Neglected Tropical Diseases 2010, WHO/HTM/NTD/2010.
2. Postigo J.A. Leishmaniasis in the World Health Organization Eastern Mediterranean region. Int. J. Antimicrob. Agents 2010, 36(Suppl. 1):S62-S65.
3. Liew F.Y. Induction, regulation and function of T cell subsets in leishmaniasis. Chem. Immunol. 1992, 54:117-135.
4. Nateghi Rostami M., Keshavarz Valian H., Eskandari S.E., et al. Differential in vitro CD4+/CD8+ T cell response to live vs. killed Leishmania major. Parasite Immunol. 2010, 32:101-110.
5. Modabber F., Buffet P.A., Torreele E., Milon G., Croft S.L. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Kinetoplastid Biol. Dis. 2007, 6:3. Institute Pasteur, Paris. 13-15 June, 2006.
6. Modabber F. Leishmaniasis vaccines: past, present and future. Int. J. Antimicrob. Agents 2010, 36(Suppl. 1):S58-S61.
7. Khamesipour A., Rafati S., Davoudi N., Maboudi F., Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J. Med. Res. 2006, 123:423-438.
8. Noazin S., Modabber F., Khamesipour A., et al. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine 2008, 26:6759-6767.
9. Seder R.A., Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 2003, 4:835-842.
10. Farber D.L. T cell memory: heterogeneity and mechanisms. Clin. Immunol. 2000, 95:173-181.
11. Schwendemann J., Choi C., Schirrmacher V., Beckhove P. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells. J. Immunol. 2005, 175:1433-1439.
12. Sallusto F., Langenkamp A., Geginat J., Lanzavecchia A. Functional subsets of memory T cells identified by CCR7 expression. Curr. Top. Microbiol. Immunol. 2000, 251:167-171.
13. Campbell J.J., Murphy K.E., Kunkel E.J., et al. CCR7 expression and memory T cell diversity in humans. J. Immunol. 2001, 166:877-884.
14. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
15. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002, 2:251-262.
16. Liew F.Y., Hale C., Howard J.G. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J. Immunol. 1982, 128:1917-1922.
17. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 1987, 138:744-749.
18. Nateghi Rostami M., Keshavarz H., Edalat R., et al. CD8+ T cells as a source of IFN-gamma production in human cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 2010, 4:e845.
19. Alimohammadian M.H., Kivanjah M., Pak F., Gaznavi A., Kharazmi A. Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins form Wellcome (UK) and Roma ( Italy ) in cured cutaneous leismaniasis patients. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:550-551.
20. Nateghi Rostami M., Keshavarz H., Khamesipour A. Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae. Trop. Biomed. 2010, 27:89-102.
21. Nateghi Rostami M., Khamesipour A., Eskandari S.E., Miramin Mohammadi A. Flow cytometric analysis of Leishmania reactive CD4+/CD8+ lymphocyte proliferation in cutaneous leishmaniasis. Iranian J. Parasitol. 2008, 3:9-18.
22. Hsieh S.M., Pan S.C., Chen S.Y., Huang P.F., Chang S.C. Age distribution for T cell reactivity to vaccinia virus in a healthy population. Clin. Infect. Dis. 2004, 38:86-89.
23. Belz G.T., Wodarz D., Diaz G., Nowak M.A., Doherty P.C. Compromised influenza virus-specific CD8+T cell memory in CD4+ T cell deficient mice. J. Virol. 2002, 76:12388-12393.
24. Cauley L.S., Cookenham T., Hogan R.J., Crowe S.R., Woodland D.L. Renewal of peripheral CD8+ memory T cells during secondary viral infection of antibody-sufficient mice. J. Immunol. 2003, 170:5597-5606.
25. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human CD8+ memory T cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101:4260-4266.
26. Caccamo N., Meraviglia S., La Mendola C., Guggino G., Dieli F., Salerno A. Phenotypical and functional analysis of memory and effector human CD8+ T cells specific for mycobacterial antigens. J. Immunol. 2006, 177:1780-1785.
27. Hailu A., van Baarle D., Knol G.J., Berhe N., Miedema F., Kager P.A. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani. Clin. Immunol. 2005, 117:182-191.
28. Berhanu D., Mortari F., De Rosa S.C., Roederer M. Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. J. Immunol. Methods 2003, 279:199-207.
29. Bozzi A., Reis B.S., Goulart M.I., Pereira M.C.N., Pedroso E.P., Goes A.M. Analysis of memory T cells in the human paracoccidioidomycosis before and during chemotherapy treatment. Immunol. Lett. 2007, 114:23-30.
30. Caccamo N., Guggino G., Meraviglia S., et al. Analysis of Mycobacterium tuberculosis specific CD8+ T cells in patients with active tuberculosis and in individuals with latent infection. PLoS One 2009, 4:e5528.
31. Saule P., Trauet J., Dutriez V., Lekeux V., Dessaint J.P., Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech. Ageing Dev. 2006, 127:274-281.
32. Champagne P., Ogg G.S., King A.S., et al. Skewed maturation of memory HIV-specific CD8+ T lymphocytes. Nature 2001, 410:106-111.
33. Fiuza J.A., Fujiwara R.T., Gomes J.A.S., et al. Profile of central and effector memory T cells in the progression of chronic human Chagas disease. PLoS Negl. Trop. Dis. 2009, 3.
34. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
35. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
36. Wherry E.J., Teichgrber V., Becker T.C., et al. Lineage relationship and protective immunity of memory CD8+ T cell subsets. Nat. Immunol. 2003, 4:225-234.
37. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845-858.
38. Muller I., Kropf P., Etges R.J., Louis J.A. Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect. Immu. 1993, 61:3730-3738.
39. Habibi G.R., Khamesipour A., McMaster W.R., Mahboudi F. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR. Scand. J. Immunol. 2001, 54:414-420.
40. Kemp K., Theander T.G., Hviid L., Garfar A., Kharazmi A., Kemp M. Interferon-gamma and tumour necrosis factor-alpha producing cells in humans who are immune to cutaneous leishmaniasis. Scand. J. Immunol. 1999, 49:655-659.
41. Bittar R.C., Nogueira R.S., Vieira-Goncalves R., et al. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis. Mem. Inst. Oswaldo Cruz 2007, 102:625-630.
42. Coutinho S.G., Pirmez C., Da-Cruz A.M. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Trans. R. Soc. Trop. Med. Hyg. 2002, 96(Suppl. 1):S173-S178.
43. Bomfim G., Andrade B.B., Santos S., Clarencio J., Barral-Netto M., Barral A. Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease. Am. J. Trop. Med. Hyg. 2007, 77:854-859.
44. Faria D.R., Souza P.E., Duraes F.V., et al. Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol. 2009, 31:432-439.
45. Woodland D.L., Kohlmeier J.E. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat. Rev. Immunol. 2009, 9:153-161.
46. Zaph C., Uzonna J., Beverley S.M., Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 2004, 10:1104-1110.
47. Sanchez M.A., Diaz N.L., Zerpa O., Negron E., Convit J., Tapia F.J. Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am. J. Trop. Med. Hyg. 2004, 70:618-624.
48. Jangpatarapongsa K., Sirichaisinthop J., Sattabongkot J., et al. Memory T cells protect against Plasmodium vivax infection. Microbes Infect. 2006, 8:680-686.
49. Prado-Garcia H., Aguilar-Cazares D., Flores-Vergara H., Mandoki J.J., Lopez-Gonzalez J.S. Effector, memory and naive CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 2005, 47:361-371.
50. Tussey L., Speller S., Gallimore A., Vessey R. Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J. Immunol. 2000, 30:1823-1829.